(Q43979184)

28 November 2017

title

High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further? (English)

1 reference

28 November 2017

author

Athanasios Dimopoulos

series ordinal

1

1 reference

28 November 2017

2

1 reference

28 November 2017

publication date

1 January 2008

1 reference

28 November 2017

1 reference

28 November 2017

volume

49

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

4-5

1 reference

Autologous stem cell transplantation for primary systemic amyloidosis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701760078

10.1080/10428190701760078

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference